Bristol-Myers Squibb's Opdivo secures a lung cancer niche with small-cell green light
admin 17th August 2018 Uncategorised 0Bristol-Myers Squibb may be trailing rival Merck in the non-small cell lung cancer market, but it’s landed a niche of its own in the small cell arena.
More: Bristol-Myers Squibb's Opdivo secures a lung cancer niche with small-cell green light
Source: fierce